Eisenberg H W
Dis Colon Rectum. 1981 Nov-Dec;24(8):610-2. doi: 10.1007/BF02605757.
A controlled, prospective, randomized study of 457 patients undergoing colonic surgery was done to compare systemic cefamandole therapy to neomycin-erythromycin in reducing postoperative septic complications. Parenteral cefamandole and cephalothin were given before, during, and after surgery to achieve maximal antimicrobial coverage in the blood, tissues, peritoneum, and urine. Such protection is not obtained with oral antibiotic preparation. Major surgical indications were carcinoma in 216 patients and diverticulitis in 107 patients. More than half the patients had colonic perforations, obstruction, or fistulas. All patients were operated upon by a single surgeon during 1975-1980. Cephalothin (151 patients), combined with neomycin-erythromycin, resulted in an 11.3 per cent rate of postoperative septic complications. Cefamandole treatment in 112 patients resulted in an 8.9 per cent postoperative infection rate compared with 16.3 per cent in 141 matched control patients.
对457例接受结肠手术的患者进行了一项对照、前瞻性、随机研究,以比较头孢孟多全身治疗与新霉素 - 红霉素在减少术后感染并发症方面的效果。在手术前、手术期间和手术后给予静脉注射头孢孟多和头孢噻吩,以在血液、组织、腹膜和尿液中实现最大程度的抗菌覆盖。口服抗生素制剂无法提供这种保护。主要手术指征为216例患者患有癌症,107例患者患有憩室炎。超过一半的患者有结肠穿孔、梗阻或瘘管。所有患者均在1975年至1980年期间由同一位外科医生进行手术。151例患者使用头孢噻吩并联合新霉素 - 红霉素,术后感染并发症发生率为11.3%。112例患者接受头孢孟多治疗,术后感染率为8.9%,而141例匹配对照患者的感染率为16.3%。